MicroRNA-Mediated Silencing of Calumenin: A Potential Strategy for Inhibiting Proliferation and Migration in Breast Cancer Cells
The results of the amiR-mediated knockdown approach support the findings that CALU is a potential promoter of BC, as evidenced by the upregulation of CALU in BC tissues and its correlation with clinicopathological features, which highlights its role in BC progression.
Authors
- Alireza Zomorodipour (ORCID: https://orcid.org/0000-0003-0671-4779)
- Mohammad Zaefizadeh (ORCID: https://orcid.org/0000-0002-4930-6065)
- Babak Jahangiri (ORCID: https://orcid.org/0000-0003-3218-3190)
- Frouzandeh Mahjoubi (ORCID: https://orcid.org/0000-0002-6880-3606)
- Fatemeh Masoumi (ORCID: https://orcid.org/0000-0002-5455-9286)
- Zahra Amiri
- Arash Javeri (ORCID: https://orcid.org/0000-0002-1064-0373)
- Fatemeh Bahrami (ORCID: https://orcid.org/0000-0002-1719-4038)
- Nahid Nafissi
Institutions
- Rasool Akram Hospital (IR)
- National Institute of Genetic Engineering and Biotechnology (IR)
- Islamic Azad University Ardabil (IR)
Publication Details
- Journal
- Advanced Pharmaceutical Bulletin
- Published
- 2025-06-11
- DOI
- https://doi.org/10.34172/apb.025.43819
- Citations
- 1
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Institute for Genetic Engineering and Biotechnology